IS7065A - Áætlun um lyfjaskammta við meðferð og lyfjasamsetningar til getnaðarvarna í neyð - Google Patents
Áætlun um lyfjaskammta við meðferð og lyfjasamsetningar til getnaðarvarna í neyðInfo
- Publication number
- IS7065A IS7065A IS7065A IS7065A IS7065A IS 7065 A IS7065 A IS 7065A IS 7065 A IS7065 A IS 7065A IS 7065 A IS7065 A IS 7065A IS 7065 A IS7065 A IS 7065A
- Authority
- IS
- Iceland
- Prior art keywords
- medication regimen
- dose medication
- emergency contraceptive
- contraceptive formulations
- formulations
- Prior art date
Links
- 239000003433 contraceptive agent Substances 0.000 title 1
- 230000002254 contraceptive effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0105173A HU227198B1 (en) | 2001-11-27 | 2001-11-27 | Pharmaceutical composition for emergency contraception containing levonorgestrel |
| PCT/HU2002/000129 WO2003045397A1 (en) | 2001-11-27 | 2002-11-26 | Dosage regimen and pharmaceutical composition for emergency contraception |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IS7065A true IS7065A (is) | 2003-12-05 |
| IS2691B IS2691B (is) | 2010-10-15 |
Family
ID=89998939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7065A IS2691B (is) | 2001-11-27 | 2003-12-05 | Áætlun um lyfjaskammta og lyfjasamsetningar til getnaðarvarnar í neyð |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US20050288264A2 (is) |
| EP (1) | EP1448207B1 (is) |
| JP (1) | JP2005516904A (is) |
| KR (1) | KR100908161B1 (is) |
| CN (1) | CN1551774A (is) |
| AP (1) | AP1849A (is) |
| AT (1) | ATE293978T1 (is) |
| AU (1) | AU2002347401A1 (is) |
| BR (1) | BR0210595A (is) |
| CA (1) | CA2450359C (is) |
| DE (1) | DE60203929T2 (is) |
| DK (1) | DK1448207T3 (is) |
| EA (1) | EA006545B1 (is) |
| EC (1) | ECSP045171A (is) |
| ES (1) | ES2239727T3 (is) |
| GE (1) | GEP20063882B (is) |
| HR (1) | HRP20040584B1 (is) |
| HU (1) | HU227198B1 (is) |
| IL (1) | IL159394A0 (is) |
| IS (1) | IS2691B (is) |
| MA (1) | MA27076A1 (is) |
| MX (1) | MXPA04005104A (is) |
| NO (1) | NO333984B1 (is) |
| NZ (1) | NZ530056A (is) |
| OA (1) | OA12730A (is) |
| PL (1) | PL206010B1 (is) |
| PT (1) | PT1448207E (is) |
| RS (1) | RS50768B (is) |
| SI (1) | SI1448207T1 (is) |
| TN (1) | TNSN04048A1 (is) |
| UA (1) | UA79942C2 (is) |
| WO (1) | WO2003045397A1 (is) |
| ZA (1) | ZA200404114B (is) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7867515B2 (en) * | 2006-12-20 | 2011-01-11 | TEVA Woman's Health, Inc. | Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof |
| WO2009082478A1 (en) * | 2007-12-20 | 2009-07-02 | Duramed Pharmaceuticals, Inc. | Dosage regimens and pharmaceutical compositions and packages for emergency contraception |
| US8512745B2 (en) | 2008-12-08 | 2013-08-20 | Laboratoire Hra Pharma | Ulipristal acetate tablets |
| EP2365811A1 (en) | 2008-12-12 | 2011-09-21 | Laboratoire HRA Pharma | A method for contraception |
| SI2419108T1 (sl) | 2009-04-14 | 2017-02-28 | Laboratorie Hra Pharma | Metoda za kontracepcijo na zahtevo |
| MX2011013959A (es) | 2009-06-23 | 2012-01-25 | Bayer Pharma AG | Composicion farmaceutica para la anticoncepcion de emergencia. |
| CN101732324B (zh) * | 2009-12-31 | 2011-12-07 | 广州朗圣药业有限公司 | 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法 |
| EA025511B1 (ru) | 2011-06-01 | 2016-12-30 | Эстетра С.П.Р.Л. | Способ получения промежуточных соединений эстетрола |
| CN107266514A (zh) | 2011-06-01 | 2017-10-20 | 埃斯特拉私人有限责任公司 | 用于产生雌四醇中间体的方法 |
| EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
| PT2741824T (pt) * | 2011-08-11 | 2017-07-06 | Estetra Sprl | Utilização de estetrol como contracetivo de emergência |
| AP2015008437A0 (en) | 2012-11-22 | 2015-05-31 | Bayer Pharma AG | Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception |
| BR112015029214A2 (pt) | 2013-05-23 | 2017-07-25 | Bayer Pharma AG | composição farmacêutica, seu uso e regime de aplicação dessa composição farmacêutica para contracepção conforme a necessidade |
| CN103877058A (zh) * | 2014-03-26 | 2014-06-25 | 邵娜 | 一种左炔诺孕酮片及其制备工艺 |
| DK3310345T3 (da) | 2015-06-18 | 2021-05-25 | Estetra Sprl | Orodispersibel tablet indeholdende estetrol |
| EA035687B1 (ru) | 2015-06-18 | 2020-07-27 | Эстетра Спрл | Диспергируемая в полости рта единица дозирования, содержащая эстетрольный компонент |
| EP3310346B1 (en) | 2015-06-18 | 2021-03-24 | Estetra SPRL | Orodispersible tablet containing estetrol |
| UA123098C2 (uk) | 2015-06-18 | 2021-02-17 | Естетра Спрл | Диспергована у порожнині рота одиниця дозування, що містить естетрольний компонент |
| CA3178291A1 (en) | 2016-08-05 | 2018-04-12 | Estetra Srl | Method for the management of dysmenorrhea and menstrual pain |
| JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
| CN110917154A (zh) * | 2019-12-12 | 2020-03-27 | 上海信谊天平药业有限公司 | 一种左炔诺孕酮片的制备方法 |
| WO2022026901A2 (en) * | 2020-07-30 | 2022-02-03 | Acer Therapeutics Inc. | Nk antagonists for contraception |
-
2001
- 2001-11-27 HU HU0105173A patent/HU227198B1/hu unknown
-
2002
- 2002-11-26 BR BR0210595-0A patent/BR0210595A/pt not_active Application Discontinuation
- 2002-11-26 AP APAP/P/2004/003046A patent/AP1849A/en active
- 2002-11-26 ES ES02783334T patent/ES2239727T3/es not_active Expired - Lifetime
- 2002-11-26 DK DK02783334T patent/DK1448207T3/da active
- 2002-11-26 UA UA20040504015A patent/UA79942C2/uk unknown
- 2002-11-26 WO PCT/HU2002/000129 patent/WO2003045397A1/en active IP Right Grant
- 2002-11-26 CA CA2450359A patent/CA2450359C/en not_active Expired - Lifetime
- 2002-11-26 DE DE60203929T patent/DE60203929T2/de not_active Expired - Lifetime
- 2002-11-26 PL PL369520A patent/PL206010B1/pl unknown
- 2002-11-26 AT AT02783334T patent/ATE293978T1/de active
- 2002-11-26 NZ NZ530056A patent/NZ530056A/en not_active IP Right Cessation
- 2002-11-26 JP JP2003546899A patent/JP2005516904A/ja not_active Withdrawn
- 2002-11-26 SI SI200230132T patent/SI1448207T1/xx unknown
- 2002-11-26 EA EA200400731A patent/EA006545B1/ru unknown
- 2002-11-26 EP EP02783334A patent/EP1448207B1/en not_active Expired - Lifetime
- 2002-11-26 MX MXPA04005104A patent/MXPA04005104A/es active IP Right Grant
- 2002-11-26 AU AU2002347401A patent/AU2002347401A1/en not_active Abandoned
- 2002-11-26 RS YUP-42/04A patent/RS50768B/sr unknown
- 2002-11-26 CN CNA028137523A patent/CN1551774A/zh active Pending
- 2002-11-26 PT PT02783334T patent/PT1448207E/pt unknown
- 2002-11-26 OA OA1200400148A patent/OA12730A/fr unknown
- 2002-11-26 KR KR1020047002069A patent/KR100908161B1/ko active IP Right Grant
- 2002-11-26 IL IL15939402A patent/IL159394A0/xx unknown
- 2002-11-26 GE GE5567A patent/GEP20063882B/en unknown
-
2003
- 2003-12-05 IS IS7065A patent/IS2691B/is unknown
-
2004
- 2004-03-26 TN TNP2004000048A patent/TNSN04048A1/en unknown
- 2004-04-20 NO NO20041607A patent/NO333984B1/no not_active IP Right Cessation
- 2004-04-21 MA MA27643A patent/MA27076A1/fr unknown
- 2004-05-26 ZA ZA2004/04114A patent/ZA200404114B/en unknown
- 2004-06-24 HR HR20040584 patent/HRP20040584B1/xx not_active IP Right Cessation
- 2004-06-25 EC EC2004005171A patent/ECSP045171A/es unknown
- 2004-10-05 US US10/495,923 patent/US20050288264A2/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS7065A (is) | Áætlun um lyfjaskammta við meðferð og lyfjasamsetningar til getnaðarvarna í neyð | |
| NO20043904L (no) | Oral doseringsform inneholdende en PDE4-hemmer som aktivt ingrediens og polyvinylpyrrolidon som eksipiens | |
| ATE307571T1 (de) | Pharmazeutische formulierung enthaltend bicalutamid | |
| IS6892A (is) | Lyfjasamsetningar, skammtaform og aðferðir til aðgefa epóþílon um munn | |
| IS7076A (is) | Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni | |
| NO20033384L (no) | Farmasoytisk formulering | |
| ATE317260T1 (de) | Pharmazeutische formulierungen mit platinderivaten | |
| ITMI20011401A0 (it) | Formulazioni farmaceutiche per ormoni tiroidei | |
| BRPI0209720A2 (pt) | dosagem e embalagem de medicação com liberação controlada | |
| ATE320807T1 (de) | Pharmazeutische zusammensetzungen enthaltend tegaserod | |
| NO20035627D0 (no) | Farmasöytisk formulering | |
| DK1210119T3 (da) | Farmaceutiske sammensætninger til oral og topisk administrering | |
| NO20043333L (no) | Farmasoytiske parvastatinformuleringer og fremgangsmater for anvendelse av dem | |
| ATE350016T1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
| DE60328119D1 (de) | Pharmazeutische zubereitungen enthaltend modafinil | |
| HK1064042A1 (en) | Medicines and medicinal kits | |
| ATE507831T1 (de) | Melatonin enthaltende pharmazeutische formulierung | |
| NO20026055L (no) | Farmasöytiske komponenter innbefattende humant paratyreoideahormon og farmasöytiske sammenstninger for nasal administrering inneholdendekomponentene | |
| DE10291905D2 (de) | Pharmazeutische Zusammensetzung | |
| DE60217369D1 (de) | Pharmazeutische zusammensetzung enthaltend gamma-butyrobetain | |
| DE10107261B4 (de) | Pharmazeutische Zusammensetzung | |
| DK1406591T3 (da) | Farmaceutisk sammensætning til nasal tilförsel af estradiol og norethisteron | |
| NO20041236L (no) | Farmasoytisk formulering | |
| ITMI20011390A0 (it) | Formulazioni farmaceutiche per ormoni tiroidei | |
| SE0101171D0 (sv) | Pharmaceutical formulation |